Senior insider sale
Chief Operating Officer at ZENTALIS PHARMACEUTICALS, INC. — senior position signals high conviction
$118.4K
6.07K shares
What this filing means
BUNKER KEVIN D. plans to sell 6.07K shares of ZENTALIS PHARMACEUTICALS, INC. valued at approximately $118.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/4/2023ACC: 0001725160-23-000170
Officer· Chief Operating Officer
Since Apr 2020
6.07K
Shares to sell
$118.4K
Approx. market value
6.07K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Release
NA
10/3/2023
6.07KTotal acquired6.07K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/3/2023 | Restricted Stock Unit Release NA | 6.07K | — |
| Total | 6.07K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
6.07K
Market value
$118.4K
10/4/2023
Total
Units
6.07K
Value
$118.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/4/2023 | 6.07K | $118.4K | NASDAQ | Planned |
| Total | 6.07K | $118.4K | ||